WGSWW Market Analysis
News & Sentiment
7 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -30.4%
- Operating margin
- -25.6%
- Revenue growth YoY
- 17.4%
- Dividend yield
- —
- Beta
- 1.91
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About GeneDx Holdings Corp.
Company profileGeneDx Holdings Corp. (Ticker: WGSWW) is a leader in the genomics sector, focusing on genomic testing and precision medicine to diagnose rare and complex genetic disorders. By harnessing advanced sequencing technologies and a robust genetic database, GeneDx empowers healthcare providers with critical diagnostic insights that support personalized treatment strategies. Its comprehensive portfolio of genetic tests, alongside strategic alliances within the healthcare industry, positions the company favorably in the marketplace and highlights its dedication to transforming personalized medicine,…
Classification
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- NORTH TOWER, STAMFORD, CT
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
